Literature DB >> 8662909

Human immunodeficiency virus type-1 reverse transcriptase. Contribution of Met-184 to binding of nucleoside 5'-triphosphate.

J E Wilson1, A Aulabaugh, B Caligan, S McPherson, J K Wakefield, S Jablonski, C D Morrow, J E Reardon, P A Furman.   

Abstract

Mutations were made in recombinant human immunodeficiency virus type-1 reverse transcriptase (RT) by substituting methionine 184 with alanine (M184A) or valine (M184V), and steady-state and pre-steady-state kinetic constants were determined. The Km values of M184A RT for dNTPs were larger than those of wt RT for RNA-directed synthesis; the kcat values of M184A RT for processive or distributive synthesis were similar. In contrast to M184A RT, the Km and kcat values of M184V RT for dNTP substrates were similar to those of wt RT. The Ki values of M184V RT for 1-beta-L-nucleoside analogs were increased 30-500-fold relative to wt RT for both RNA- and DNA-directed synthesis. The Kd and kp values of wt RT and M184V RT for dCTP and cis-5-fluoro-1-[2-(hydroxymethyl)-1, 3-oxathiolan-5-yl]cytosine 5'-triphosphate (1-beta-L-FTCTP) were estimated from pre-steady-state kinetics for single nucleotide incorporation. The Kd value of M184V RT for 1-beta-L-FTCTP was 19-fold greater than that of wt RT; the kpvalues of the two enzymes were similar. These results support the hypothesis that methionine 184 in the highly conserved YMDD region of wt RT participates in the binding of the nucleoside (analog) 5'-triphosphate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662909     DOI: 10.1074/jbc.271.23.13656

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidine.

Authors:  R A Smith; G J Klarmann; K M Stray; U K von Schwedler; R F Schinazi; B D Preston; T W North
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.

Authors:  Lu Gao; Mark Nils Hanson; Mini Balakrishnan; Paul L Boyer; Bernard P Roques; Stephen H Hughes; Baek Kim; Robert A Bambara
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

3.  Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro.

Authors:  W C Drosopoulos; V R Prasad
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket.

Authors:  Nootan Pandey; Chaturbhuj A Mishra; Dinesh Manvar; Alok K Upadhyay; Tanaji T Talele; Thomas W Comollo; Neerja Kaushik-Basu; Virendra N Pandey
Journal:  Biochemistry       Date:  2011-08-23       Impact factor: 3.162

5.  A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.

Authors:  Antonio J Acosta-Hoyos; Suzanne E Matsuura; Peter R Meyer; Walter A Scott
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

6.  YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.

Authors:  P L Boyer; H Q Gao; P K Clark; S G Sarafianos; E Arnold; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.

Authors:  Kirsten L White; Nicolas A Margot; Terri Wrin; Christos J Petropoulos; Michael D Miller; Lisa K Naeger
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptases with amino acid substitutions affecting Tyr115.

Authors:  A M Martín-Hernández; M Gutiérrez-Rivas; E Domingo; L Menéndez-Arias
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

9.  Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases.

Authors:  Maximilian J Hartl; Florian Mayr; Axel Rethwilm; Birgitta M Wöhrl
Journal:  Retrovirology       Date:  2010-01-29       Impact factor: 4.602

10.  Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.

Authors:  Ann W Walsh; David R Langley; Richard J Colonno; Daniel J Tenney
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.